Home » ELEKTA RECEIVES U.S. REGULATORY APPROVAL FOR TREATMENT PLANNING ON LEKSELL GAMMA KNIFE PERFEXION
ELEKTA RECEIVES U.S. REGULATORY APPROVAL FOR TREATMENT PLANNING ON LEKSELL GAMMA KNIFE PERFEXION
The U.S. Federal Drug Administration (FDA) announced a 510(k) pre-market clearance for Leksell GammaPlan PFX, the treatment planning
system developed for Leksell Gamma Knife Perfexion.
Genetic
Engineering News
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May